Human Papillomavirus Vaccination Status and Its Predictors Among Medical Students

Yıl 2025, Cilt: 35 Sayı: 6, 1190 - 1204, 31.12.2025

Özgür Önal , Merve Hayrunnisa Akyol , Pelin Özkan Buyruk , Ersin Uskun , Ahmet Nesimi Kişioğlu

https://doi.org/10.54005/geneltip.1720241

Öz

Aim: The aim of this study was to examine the Human Papillomavirus (HPV) vaccination status of medical students and the factors influencing it.
Methods: This cross-sectional study was conducted among students enrolled in the Faculty of Medicine at Suleyman Demirel University during the 2024–2025 academic year. A total of 1,179 completed responses were obtained. In addition to assessing participants’ HPV vaccination status, the study included the HPV Knowledge Scale (HPV-KS), the Health Belief Model Scale for HPV and Vaccination (HPV-HBMS), and various sociodemographic variables.
Results: The HPV vaccination rate among the participants was 5.9%. Backward logistic regression analysis identified several significant independent predictors of HPV vaccination. Being female increased the likelihood of vaccination by 5.56 times compared to males. Regular medication use was associated with 2.04 times higher odds. Having a mother employed as a healthcare worker increased the odds by 2.25 times. A positive perception of family economic status was associated with a 1.90 times higher likelihood compared to an average or poor perception. A family history of cervical cancer increased the odds by 4.58 times. Having a boyfriend or girlfriend was associated with 1.92 times higher odds. Additionally, each one- point increase in knowledge about the current HPV vaccination program increased the likelihood of vaccination by 1.43 times.
Conclusions: Although medical students have easy access to health-related information, the low HPV vaccination rate suggests that factors beyond knowledge—such as attitudes and beliefs—also play a critical role. Therefore, comprehensive educational programs that address not only knowledge but also health beliefs and attitudes should be implemented in medical schools.

Anahtar Kelimeler

Human papillomavirus , vaccine , medical students , knowledge

Tıp Fakültesi Öğrencileri Arasında İnsan Papilloma Virüsüne Karşı Aşılanma Durumu ve Belirleyicileri

Öz

Amaç: Bu çalışmanın amacı, tıp fakültesi öğrencilerinin HPV aşılanma durumunu ve bunu
etkileyen faktörleri incelemektir.
Gereç ve Yöntemler: Bu kesitsel çalışma, 2024-2025 akademik yılı boyunca Süleyman Demirel Üniversitesi Tıp Fakültesi’ne kayıtlı öğrenciler arasında yürütülmüştür. Toplam 1.179 tamamlanmış yanıt elde edilmiştir. Katılımcıların HPV aşılanma durumuna ek olarak, çalışmada HPV Bilgi Ölçeği (HPV-KS), HPV ve Aşılama için Sağlık İnanç Modeli Ölçeği (HPV-HBMS) ile sosyodemografik değişkenler değerlendirilmiştir.
Bulgular: Katılımcılar arasında HPV aşılanma oranı %5,9 olarak bulunmuştur. Geriye doğru yapılan lojistik regresyon analizi, HPV aşılanma durumunu anlamlı şekilde yordayan bağımsız değişkenleri ortaya koymuştur. Kadın olmak, erkeklere kıyasla aşılanma olasılığını 5,56 kat artırmıştır. Düzenli ilaç kullananların aşılanma olasılığı 2,04 kat daha yüksektir. Annesi sağlık çalışanı olan bireylerde aşılanma olasılığı 2,25 kat artmıştır. Ailesinin ekonomik durumunu olumlu olarak algılayan bireylerin, ortalama/kötü algılayanlara göre aşılanma olasılığı 1,90 kat daha yüksektir. Ailede serviks kanseri öyküsü olan bireylerde aşılanma olasılığı 4,58 kat artmıştır. Sevgilisi olan bireylerde ise aşılanma olasılığı 1,92 kat daha fazladır. Ayrıca, mevcut HPV aşı programına yönelik bilgi düzeyindeki her bir puanlık artış, aşılanma olasılığını 1,43 kat artırmaktadır.
Sonuçlar: Tıp öğrencilerinin sağlıkla ilgili bilgilere kolay erişimi olmasına rağmen HPV aşılanma oranının düşük olması, yalnızca bilgi değil; tutum ve inanç gibi diğer faktörlerin de önemli rol oynadığını göstermektedir. Bu nedenle, sadece bilgi düzeyini artırmayı hedefleyen değil, aynı zamanda sağlık inançları ve tutumları da ele alan kapsamlı eğitim programları tıp fakültelerinde uygulanmalıdır.

Anahtar Kelimeler

İnsan papilloma virüsü , aşı , tıp fakültesi öğrencileri , bilgi

Kaynakça

• 1. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global Burden of Human Papillomavirus and Related Diseases. Vaccine 2012;30:F12–23.
• 2. Moscicki A-B, Palefsky JM. Human Papillomavirus in Men. J Low Genit Tract Dis 2011;15:231–4.
• 3. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah K V., et al. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. New England Journal of Medicine 2003;348:518–27.
• 4. Lyon. IARC Monographs on the Evaluation of Carcinogenic iRisks to Humans. IARC 1995;64.
• 5. Okay A, Soydam Aydin S, Akin L. Social impacts following the use of Human Papillomavirus (HPV) vaccines. Bolu Abant Izzet Baysal University Faculty of Medicine, Abant Medical Journal. 2022;11:143–51.
• 6. Petca A, Borislavschi A, Zvanca M, Petca R-C, Sandru F, Dumitrascu M. Non-sexual HPV transmission and role of vaccination for a better future (Review). Exp Ther Med 2020;20:1–5.
• 7. CDC. Cancers Caused by HPV. CDC 2024. Available from: https://www.cdc.gov/hpv/about/cancers-caused-by-hpv.html
• 8. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74:229–63.
• 9. World Health Organization (WHO). Human papillomavirus and cancer 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer
• 10. Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet 2012;285:771–7.
• 11. ACOG. Updated Cervical Cancer Screening Guidelines. Clinical 2021. Available from: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated- cervical-cancer-screening-guidelines
• 12. Bruni L., Albero G., Serrano B., Mena M., Collado JJ., Gómez D., et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Turkey. Summary Report 10 March 2023. . ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre) 2023.
• 13. Hantz S, Alain S, Denis F. Vaccins prophylactiques antipapillomavirus : enjeux et perspectives. Gynecol Obstet Fertil 2006;34:647–55.
• 14. World Health Organization. Human papillomavirus vaccines: WHO position paper (2022 update). World Health Organization (WHO) 2022. Available from: https://www.who.int/publications/i/item/who-wer9750-645-672
• 15. Dal O, Gafarli L, Karagoz MI, Cakir Gungor AN. Current approaches to the Human Papillomavirus (HPV) vaccine. Cukurova Medical Student Journal. 2024;4:18–23.
• 16. Champion VL., Skinner CS. The health belief model. In: Glanz K, Rimer BK, Viswanath K, editors. Health behavior and health education: theory, research, and practice. 4th ed. , San Francisco: Jossey-Bass; 2008, p. 45–65.
• 17. Kim HW. Knowledge about human papillomavirus (HPV), and health beliefs and intention to recommend HPV vaccination for girls and boys among Korean health teachers. Vaccine 2012;30:5327–34.
• 18. Guvenc G, Seven M, Akyuz A. Health Belief Model Scale for Human Papilloma Virus and its Vaccination: Adaptation and Psychometric Testing. J Pediatr Adolesc Gynecol 2016;29:252–8.
• 19. Donmez S, Ozturk R, Kisa S, Karaoz Weller B, Zeyneloglu S. Knowledge and perception of female nursing students about human papillomavirus (HPV), cervical cancer, and attitudes toward HPV vaccination. Journal of American College Health 2019;67:410–7.
• 20. Yoruk S, Acikgoz A, Ergor G. Determination of knowledge levels, attitude and behaviors of female university students concerning cervical cancer, human papiloma virus and its vaccine. BMC Womens Health 2016;16:51.
• 21. Yilmaz Ozdemir R, Marakoglu K, Korez MK. Evaluation of Knowledge, Attitudes and Behaviors of Medical Faculty Students about HPV and HPV Vaccine. Turkish Journal of Family Practice 2023;27:88–94.
• 22. Waller J, Ostini R, Marlow LAV, McCaffery K, Zimet G. Validation of a measure of knowledge about human papillomavirus (HPV) using item response theory and classical test theory. Prev Med (Baltim) 2013;56:35–40.
• 23. Bozkurt FD, Ozdemir S. Validity and reliability of a Turkish version of the human papillomavirus knowledge scale: a methodological study. J Turk Ger Gynecol Assoc 2023;24:177. 24. Cohen J. Statistical power analysis. Current Directions in Psychological Science. 1992;1(3):98–101.
• 25. Chowdhury MZİ, Turin TC. Variable selection strategies and its importance in clinical prediction modelling. Family Medicine and Community Health. 2020;8(1).
• 26. Yagan Z, Aldanmaz A, Ertugrul T, Tolan ZB, Menderes Bilgic A, Bilgic A. Evaluation of knowledge and attitudes of the faculty of medicine students about human papillomavirus infections, related cancers, and human papillomavirus vaccines. Turkderm-Turk Arch Dermatol Venereo 2023:9–15.
• 27. Duzova M, Kucukkinali S, et al. Knowledge, attitudes and behaviors of medical school students about HPV, HPV vaccine and cervical cancer: a survey study in a medical school. Gen Med J. 2022;32:724–9.
• 28. Mirza A, Col M. Knowledge, attitudes and behaviors of intern doctors about HPV infection and its vaccine in a medical faculty. ESTUDAM Public Health J. 2023;8:183–93.
• 29. Guducu N, Gonenc G, Isci H, Yigiter AB, Dunder I. Awareness of human papilloma virus, cervical cancer and HPV vaccine in healthcare workers and students of medical and nursing schools. Journal of Clinical and Experimental Investigations 2012;3.
• 30. Rashwan HH, Mohd Saat NZN, Abd Manan DN. Knowledge, Attitude and Practice of Malaysian Medical and Pharmacy Students Towards Human Papillomavirus Vaccination. Asian Pacific Journal of Cancer Prevention 2012:2279–83.
• 31. Swarnapriya K, Kavitha D, Mohan Reddy GM. Knowledge, Attitude and Practices Regarding HPV Vaccination Among Medical and Para Medical in Students, India a Cross Sectional Study. Asian Pacific Journal of Cancer Prevention 2016;16:8473–7.
• 32. de Souza Costa A, Gomes JM, Germani ACCG, da Silva MR, de Sousa Santos EF, Júnior JMS, et al. Knowledge gaps and acquisition about HPV and its vaccine among Brazilian medical students. PLoS One 2020;15.
• 33. Biselli-Monteiro M, Ferracini AC, Sarian LO, Derchain SFM. Influence of Gender and Undergraduate Course on the Knowledge about HPV and HPV Vaccine, and Vaccination Rate among Students of a Public University. Revista Brasileira de Ginecologia e Obstetricia 2020;42:96–105. 34. Aldawood E, Dabbagh D, Alharbi S, Alzamil L, Faqih L, Alshurafa HH, et al. HPV Vaccine Knowledge and Hesitancy Among Health Colleges’ Students at a Saudi University. J Multidiscip Healthc 2023;16:3465–76.
• 35. Dorji T, Nopsopon T, Tamang ST, Pongpirul K. Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis. EClinicalMedicine 2021;34:100836.
• 36. Zhou L, Wang J, Cheng P, Li Y, Liu G, Zhang X. HPV Vaccine Hesitancy Among Medical Students in China: A Multicenter Survey. Front Public Health 2022;10:774767.
• 37. Padmanabha N, Kini JR, Alwani AA, Sardesai A. Acceptability of human papillomavirus vaccination among medical students in Mangalore, India. Vaccine 2019;37:1174–81.
• 38. Fu CJ, Pan XF, Zhao ZM, Saheb-Kashaf M, Chen F, Wen Y, et al. Knowledge, Perceptions and Acceptability of HPV Vaccination among Medical Students in Chongqing, China. Asian Pacific Journal of Cancer Prevention 2014;15:6187–93.
• 39. McCusker SM, MacQueen I, Lough G, MacDonald AI, Campbell C, Graham S V. Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland. BMC Public Health 2013;13:1–7.
• 40. Sahin HO, Ozerdogan O, Duran N. Family Practice and Palliative Care. Family Practice and Palliative Care 2020:69–75.
• 41. Adejuyigbe FF, Balogun BR, Sekoni AO, Adegbola AA. Cervical Cancer and Human Papilloma Virus Knowledge and Acceptance of Vaccination among Medical Students in Southwest Nigeria. Afr J Reprod Health 2015;19:140–8.
• 42. Iliyasu Z, Galadanci HS, Muhammad A, Iliyasu BZ, Umar AA, Aliyu MH. Correlates of human papillomavirus vaccine knowledge and acceptability among medical and allied health students in Northern Nigeria. J Obstet Gynaecol (Lahore) 2022;42:452–60.
• 43. Newman PA, Logie CH, Doukas N, Asakura K. HPV vaccine acceptability among men: a systematic review and meta-analysis. Sex Transm Infect 2013;89:568–74.
• 44. Cinar I, Ozkan S, Aslan G, Alatas E. Knowledge and Behavior of University Students toward Human Papillomavirus and Vaccination. Asia Pac J Oncol Nurs 2019;6:300–7. 45. Tasci ES, Bas D, Kayak S, Anik S, Erozcan A, Sonmez O. Assessment of health literacy and HPV knowledge among university students: An observational study. Medicine (United States) 2024;103.
• 46. Kitur H, Horowitz AM, Beck K, Wang MQ. HPV Knowledge, Vaccine Status, and Health Literacy Among University Students. Journal of Cancer Education 2022;37:1606–13.
• 47. Sen MA, Ak EY. The relationship between knowledge levels of HPV and health literacy in youth – an example from Turkiye. European Journal of Clinical and Experimental Medicine 2024;22:279–85.
• 48. Usca Y, Kocak HS. Knowledge, Beliefs and Vaccination Status of Nursing Students about Human Papilloma Virus. Asian Pacific Journal of Cancer Care 2024;9:481–8.
• 49. Daniel CL, McLendon L, Green CL, Anderson KJ, Pierce JY, Perkins A, et al. HPV and HPV Vaccination Knowledge and Attitudes Among Medical Students in Alabama. Journal of Cancer Education 2021;36:168–77.
• 50. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007;45:107–114.
• 51. Alsulami FT, Sanchez J, Rabionet SE, Popovici I, Baraka MA. Predictor of HPV Vaccination Uptake among Foreign-Born College Students in the U.S.: An Exploration of the Role of Acculturation and the Health Belief Model. Vaccines 2023, Vol 11, Page 422 2023;11:422.
• 52. Fallucca A, Immordino P, Riggio L, Casuccio A, Vitale F, Restivo V. Acceptability of HPV Vaccination in Young Students by Exploring Health Belief Model and Health Literacy. Vaccines 2022, Vol 10, Page 998 2022;10:998.
• 53. Yufika A, Wagner AL, Nawawi Y, Wahyuniati N, Anwar S, Yusri F, et al. Parents’ hesitancy towards vaccination in Indonesia: A cross-sectional study in Indonesia. Vaccine 2020;38:2592–9.
• 54. Khatatbeh M, Albalas S, Khatatbeh H, Momani W, Melhem O, Al Omari O, et al. Children’s rates of COVID-19 vaccination as reported by parents, vaccine hesitancy, and determinants of COVID-19 vaccine uptake among children: a multi-country study from the Eastern Mediterranean Region. BMC Public Health 2022;22:1–11.
• 55. Troha M, Šterbenc A, Mlaker M, Poljak M. Human papillomavirus (HPV) infection and vaccination: knowledge and attitudes among healthcare professionals and the general public in Slovenia. Acta Dermatovenerol APA 2018;27:59–64. 56. Xie H, Zhu HY, Jiang NJ, Yin YN. Awareness of HPV and HPV vaccines, acceptance to vaccination and its influence factors among parents of adolescents 9 to 18 years of age in China: A cross-sectional study. J Pediatr Nurs 2023;71:73–8.
• 57. Della Polla G, Pelullo CP, Napolitano F, Angelillo IF. HPV vaccine hesitancy among parents in Italy: a cross-sectional study. Hum Vaccin Immunother 2020;16:2744–51.
• 58. Jeudin P, Liveright E, Del Carmen MG, Perkins RB. Race, Ethnicity, and Income Factors Impacting Human Papillomavirus Vaccination rates. Clin Ther 2014;36:24–37.
• 59. Murfin J, Irvine F, Meechan-Rogers R, Swift A. Education, income and occupation and their influence on the uptake of cervical cancer prevention strategies: A systematic review. J Clin Nurs 2020;29:393–415.
• 60. Cesmeci Y, Koylu B, Sulaiman J, Sancak E, Senel S, Ertug Baki H, et al. HPV infections and HPV vaccine from the perspective of interns. Turk J Gynecol Oncol. 2015;18:85–92.
• 61. Uzuner A, Arabaci S, Yuceel AI, Kocaturk AC, Kaynar E, Khan A. Knowledge, attitudes and behaviors of adults regarding adult vaccinations. Turk J Fam Med Prim Care. 2018;12:215–25.
• 62. Bernat DH, Gerend MA, Chevallier K, Zimmerman MA, Bauermeister JA. Characteristics Associated With Initiation of the Human Papillomavirus Vaccine Among a National Sample of Male and Female Young Adults. Journal of Adolescent Health 2013;53:630–6.
• 63. Lindley LL, Elkind JS, Landi SN, Brandt HM. Receipt of the Human Papillomavirus Vaccine Among Female College Students in the United States, 2009. Journal of American College Health 2013;61:18–27.
• 64. Laz TH, Rahman M, Berenson AB. Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States. Cancer 2013;119:1386–92.